Fibroblast growth factor-23 but not sKlotho levels are related to diastolic dysfunction in type 1 diabetic patients with early diabetic nephropathy

被引：0
|
作者：
Burcu Dogan
Izzet Hakki Arikan
Derya Guler
Nursen Keles
Banu Isbilen
Ferruh Isman
Aytekin Oguz
机构：
[1] Istanbul Medeniyet University,Department of Family Physicians
[2] Goztepe Training and Research Hospital,Department of Nephrology
[3] Marmara University Pendik Hospital,Department of Cardiology
[4] Istanbul Medeniyet University,Department of Clinical Chemistry
[5] Goztepe Training and Research Hospital,Department of Internal Medicine
[6] Istanbul Medeniyet University,undefined
[7] Goztepe Training and Research Hospital,undefined
[8] Istanbul Medeniyet University,undefined
[9] Goztepe Training and Research Hospital,undefined
来源：
International Urology and Nephrology | 2016年 / 48卷
关键词：
Type 1 diabetes mellitus; sKlotho; FGF-23; Cardiac function; Diabetic nephropathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：399 / 407
页数：8
相关论文
共 50 条
  • [41] Prevention of Diabetic Nephropathy by Modified Acidic Fibroblast Growth Factor
    Pena, Ana M.
    Chen, Shali
    Feng, Biao
    Cai, Lu
    Li, Xiaokun
    Liang, Guang
    Chakrabarti, Subrata
    NEPHRON, 2017, 137 (03) : 221 - 236
  • [42] Fibroblast Growth Factor-19 Levels in Type 2 Diabetic Patients with Metabolic Syndrome
    Barutcuoglu, Burcu
    Basol, Gunes
    Cakir, Yasemin
    Cetinkalp, Sevki
    Parildar, Zuhal
    Kabaroglu, Ceyda
    Ozmen, Dilek
    Mutaf, Isil
    Bayindir, Oya
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2011, 41 (04): : 390 - 396
  • [43] FIBROBLAST GROWTH FACTOR-19 LEVELS IN TYPE 2 DIABETIC PATIENTS WITH METABOLIC SYNDROME
    Barutcuoglu, B.
    Basol, G.
    Cakir, Y.
    Cetinkalp, S.
    Parildar, Z.
    Kabaroglu, C.
    Ozmen, D.
    Mutaf, I.
    Bayindir, O.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S367 - S367
  • [44] VARIABILITY AND COMPARISON OF SERUM AND PLASMA FIBROBLAST GROWTH FACTOR-23 (FGF-23) LEVELS IN HAEMODIALYSIS PATIENTS
    Damasiewicz, M.
    Kerr, P.
    Lu, Z.
    Tudball, R.
    Polkinghorne, K.
    NEPHROLOGY, 2014, 19 : 21 - 21
  • [45] Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients
    Nakanishi, S
    Kazama, JJ
    Nii-Kono, T
    Omori, K
    Yamashita, T
    Fukumoto, S
    Gejyo, F
    Shigematsu, T
    Fukagawa, M
    KIDNEY INTERNATIONAL, 2005, 67 (03) : 1171 - 1178
  • [46] Evaluation of alpha Klotho and fibroblast growth factor-23 levels in Iraqi patients with Graves' disease
    Rashid, Munaf Faraj
    Alammar, Haider Abd Jabbar
    Rahmah, Abbas Mahdi
    ANAESTHESIA PAIN & INTENSIVE CARE, 2024, 28 (05) : 836 - 841
  • [47] Progression of diabetic nephropathy in type 1 diabetic patients
    Najafian, Behzad
    Mauer, Michael
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (01) : 1 - 8
  • [48] Early diagnosis of LV diastolic dysfunction for diabetic patients
    Joshi, Manjusha
    Desai, K. D.
    Menon, M. S.
    INTERNATIONAL JOURNAL OF BIOMEDICAL ENGINEERING AND TECHNOLOGY, 2014, 14 (03) : 233 - 242
  • [49] Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy
    Roestenberg, P
    van Nieuwenhoven, FA
    Wieten, L
    Boer, P
    Diekman, T
    Tiller, AM
    Wiersinga, WM
    Oliver, N
    Usinger, W
    Weitz, S
    Schlingemann, RO
    Goldschmeding, R
    DIABETES CARE, 2004, 27 (05) : 1164 - 1170
  • [50] Evaluating the Fibroblast Growth Factor-23 and Phosphate in Iraqi Patients with Acromegaly
    Kashash, Sara A.
    Hameed, Areej Sh.
    BAGHDAD SCIENCE JOURNAL, 2024, 21 (03) : 1037 - 1043
12345